Nov. 30, 2004 — The U.S. Food and Drug Administration (FDA) and King Pharmaceuticals, Inc., have notified healthcare professionals via letter of labeling changes for existing prescribing and route of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results